
北美医药中间体市场预测至 2028 年 - COVID-19 影响和按类型(GMP 和非 GMP)、应用(抗生素、解热镇痛药、维生素等)和分销渠道(分销商和直销)进行的区域分析
No. of Pages: 115 | Report Code: TIPRE00025456 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00025456 | Category: Life Sciences
北美由三个主要国家组成,即美国、加拿大、墨西哥。还对北美其他市场进行了评估。美国和加拿大等国家市场的增长是由生产原料药的医药中间体需求不断增加、通过提高药品生产的举措不断增加的支持以及生物制药行业的研发不断增加等因素推动的。此外,墨西哥等国家不断增长的制药业预计将在预测期内为市场提供增长机会。美国是全球最大的医药中间体市场。该市场的增长归因于产品开发的增加、仿制药产量的增加以及政府对加强制药和生物制药行业的支持不断增加。此外,慢性病和急性病发病率的不断上升也间接导致了市场的增长。慢性病和传染病患病率的增加是推动北美医药中间体市场增长的主要因素。
自COVID-19爆发以来,北美的病例数量不断增加。例如,根据 Worldometer 的数据,截至 2021 年 4 月,美国的病例数增加至 31,990,143 例,死亡人数为 576,298 人。墨西哥和加拿大的病例数也在增加。截至 2021 年 4 月,墨西哥的病例已达到 2,281,840 例,死亡人数为 209,702 人。同样,在加拿大,截至 2021 年 4 月报告的新冠肺炎病例约为 1,071,016 例。这一流行病正在给全球公共卫生系统带来压力,中断和推迟了许多类型的治疗。关键的医疗保健。世界卫生组织最近的一项调查发现,卫生服务是最常受到干扰的服务之一。全球十分之七的国家以及美国、加拿大和墨西哥都正在经历中断。然而,根据 IRI 的数据,美国新冠病毒大流行爆发后,对各种膳食补充剂的需求以前所未有的速度激增。 2020 年 3 月第一周,补充剂总销售额增长了 6%。此外,由于保持社交距离,消费者的日常美容和皮肤护理正在发生变化。这导致对可在家使用的营养产品的需求增加。此外,新冠患者发病率的上升增加了北美地区对镇痛药的需求。
北美医药中间体市场根据类型、应用、分销渠道和国家进行细分。根据类型,市场分为 GMP 和非 GMP。 2020 年,GMP 领域在市场上占据主导地位,预计将在预测期内增长最快。根据应用,医药中间体市场分为抗生素、解热镇痛药、维生素等。其他细分市场在 2020 年占据市场主导地位,维生素细分市场预计将在预测期内增长最快。根据分销渠道,医药中间体市场分为经销商和直销。直销细分市场在 2020 年占据主导地位,分销细分市场预计将在预测期内增长最快。
准备本北美医药中间体市场报告时参考的一些主要一手和二手资料包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有巴斯夫股份公司(BASF SE);奇拉康有限公司;法典; Dishman Carbogen Amcis 有限公司;迈达斯制药有限公司;辉瑞公司;赛诺菲; Vertellus Holdings LLC 就是其中之一。
Strategic insights for North America Pharmaceutical Intermediates involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 11,054.47 Million |
Market Size by 2028 | US$ 14,927.32 Million |
Global CAGR (2021 - 2028) | 4.4% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Pharmaceutical Intermediates refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Pharmaceutical Intermediates Market is valued at US$ 11,054.47 Million in 2021, it is projected to reach US$ 14,927.32 Million by 2028.
As per our report North America Pharmaceutical Intermediates Market, the market size is valued at US$ 11,054.47 Million in 2021, projecting it to reach US$ 14,927.32 Million by 2028. This translates to a CAGR of approximately 4.4% during the forecast period.
The North America Pharmaceutical Intermediates Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pharmaceutical Intermediates Market report:
The North America Pharmaceutical Intermediates Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pharmaceutical Intermediates Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pharmaceutical Intermediates Market value chain can benefit from the information contained in a comprehensive market report.